Core Viewpoint - ZhenDe Medical Products Co., Ltd. reported a slight increase in revenue for the first half of 2025, but a significant decline in net profit due to various operational challenges and market conditions [1][2]. Company Overview and Financial Indicators - ZhenDe Medical was established in 1994 and integrates R&D, production, and sales in the medical and health industry [3]. - The company achieved operating revenue of CNY 2.1 billion in the first half of 2025, a 2.83% increase from the previous year [2]. - The total profit for the period was CNY 157 million, down 20.61% year-on-year, with net profit attributable to shareholders at CNY 127.76 million, a decrease of 20.70% [2][3]. - The company’s net assets were CNY 5.63 billion, showing a slight decrease of 0.20% compared to the end of the previous year [2]. Business Operations - The company has a comprehensive product line covering various medical fields, including modern wound care, surgical infection control, and personal health care products [3][4]. - ZhenDe Medical has established a global marketing network, with products sold in over 70 countries and regions [3]. - The company’s domestic sales strategy includes both direct sales and partnerships with distributors, covering nearly 9,200 hospitals in China [3][4]. Industry Context - The global medical device market is projected to grow steadily, driven by an aging population and increasing health awareness, with an estimated market size of USD 603.1 billion in 2024 [11][12]. - The Chinese medical device market is expected to reach CNY 106.38 billion in 2024, reflecting a growth rate of 3% [11][12]. - The low-value medical consumables market in China is anticipated to grow to CNY 134.4 billion in 2024, with a year-on-year increase of 5% [11][12]. - The industry is experiencing a shift towards higher concentration, with larger companies gaining market share due to their comprehensive R&D capabilities [11][12].